Drug combination for advanced gynecological cancers
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests a new drug combination (called 9MW2821 with other cancer drugs) for women with advanced gynecological cancers that have not responded to other treatments. The goal is to see if the combination is safe and effective in shrinking tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman aged 18 to 75.
- You must have an advanced gynecological cancer (like ovarian, cervical, or uterine) that is confirmed by biopsy.
- You should be generally active (able to do light housework or office work).
- You must be willing to provide a sample of your tumor tissue for testing.
- You must have at least one tumor that can be measured on scans.
- You should not have had another cancer in the past 3 years (except certain skin cancers).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called BL-M09D1 for people with certain gynecologic cancers or other solid tumors that have not responded to standard treatment. The goal is to see if the drug can shrink tumors or slow their growth, and to check its safety.
This trial tests a new drug, 9MW2821 (sometimes with a PD-1 inhibitor), for people with advanced triple-negative breast cancer. It may be an option if you've already tried standard treatments or haven't started any yet.
This study tests a new drug (9MW2821) against standard chemotherapy for people with triple-negative breast cancer that has spread or come back after prior treatments. The new drug is designed to target and destroy cancer cells more precisely, potentially offering better outcomes.
This trial tests a new drug combined with other anti-cancer drugs for advanced breast cancer. The goal is to see if the combination can shrink tumors and help people live longer, and if it is safe.
This trial tests a combination of two investigational drugs, MHB036C and MHB039A, in people with advanced breast cancer or other solid tumors that have spread. The goal is to see if this combination can shrink tumors and help patients live longer.
This trial tests a combination of two experimental drugs, MHB088C and MHB039A, for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if this combination can shrink tumors and help patients live longer.
Hear when a new Gynecological Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.